sprite-preloader
Anzeige
Mehr »
Freitag, 22.02.2019 Börsentäglich über 12.000 News von 595 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von BioPharma-Reporter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoWuXi Biologics expects to receive EU GMP nod in matter of months
DoATS harnesses electromagnetic technology for cell minimizing unit
MiNovartis doubles investment in AveXis gene therapy site
MiHuman genome editing committee created after industry calls for standards
MiFour-pronged partnership to produce automated systems for CRISPR
DiPfizer secures European approval for Avastin biosimilar
DiCanada rejects biologic suffix addition leaving US sole proponent
DiMedImmune will cease to exist after 30 years
DiEuropean manufacturing waiver to 'level the playing field'
15.02.Hired and Retired: Pharma C-suites see new faces
14.02.FDA observes manipulation of data at Immunomedics facility
14.02.'The orchestrators of the immune system': Partnership develops antibody therapies
13.02.WuXi Biologics enters first commercial manufacturing agreement
13.02.Biotech licenses protein production tech to Eli Lilly
13.02.Clinigen pays Novartis $210m for US rights to Proleukin
12.02.Samsung Bioepis expands in China with second partner in two months
12.02.AbbVie enters $90m agreement to develop multiple myeloma immunotherapy
12.02.Biosimilar entry into US insulin market will see 'millions more patients treated'
08.02.CAR-T for solid tumors drives industry to innovate
07.02.Sanofi nanobody drug first approved to treat rare blood disorder
07.02.Teva highlights quarterly dosing of migraine med as EU gives positive opinion
07.02.RNAi research blooms with yeast-based production
06.02.Fujifilm 'combining forces' to create bioprocessing center of excellence
06.02.Kymriah to be affordable to eligible patients in the UK
05.02.GSK indicates oncology intent with €3.7bn Merck deal